Validation of a chloroquine-induced cell death mechanism for clinical use against malaria.
An alternative antimalarial pathway of an 'outdated' drug, chloroquine (CQ), may facilitate its return to the shrinking list of effective antimalarials. Conventionally, CQ is believed to interfere with hemozoin formation at nanomolar concentrations, but resistant parasites are able to effl...
Auteurs principaux: | Ch'ng, J, Lee, Y, Gun, S, Chia, W, Chang, Z, Wong, L, Batty, K, Russell, B, Nosten, F, Renia, L, Tan, K |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Nature Publishing Group
2014
|
Sujets: |
Documents similaires
-
Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia
par: Sutanto, I, et autres
Publié: (2010) -
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
par: Price, R, et autres
Publié: (2007) -
Malaria : obstacles and opportunities /
par: Institute of Medicine (U.S.), Committe for the study on malaria prevention and control : status review and atternative strategies, et autres
Publié: (1991) - Akta pembasmi malaria, 1971
-
Malaria : genetic and evolutionary aspects /
par: Dronamraju, Krishna R., et autres
Publié: (2006)